BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 7890546)

  • 1. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H; Stephan K; Böheim K; Welzl-Müller K
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibility for quantitative and frequency-specific assessment of auditory threshold with otoacoustic emissions].
    Dreher A; Suckfüll M; Schneeweiss S; Schorn K
    Laryngorhinootologie; 1997 Jan; 76(1):2-7. PubMed ID: 9156504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
    Groh D; Pelanova J; Jilek M; Popelar J; Kabelka Z; Syka J
    Hear Res; 2006 Feb; 212(1-2):90-8. PubMed ID: 16364580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion product otoacoustic emissions and tympanometric measurements in an adult population-based study.
    Uchida Y; Ando F; Nakata S; Ueda H; Nakashima T; Niino N; Shimokata H
    Auris Nasus Larynx; 2006 Dec; 33(4):397-401. PubMed ID: 16753276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transiently evoked otoacoustic emissions in patients with cerebellopontine angle tumors.
    Cane MA; Lutman ME; O'Donoghue GM
    Am J Otol; 1994 Mar; 15(2):207-16. PubMed ID: 8172303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Otoacoustic distortion products in sensorineural hearing loss in the cochlea].
    Ricci G; Molini E; Fantera A; Manna V; Simoncelli C
    Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):492-500. PubMed ID: 9381918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions.
    Erdem T; Ozturan O; Miman MC; Ozturk C; Karatas E
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):62-6. PubMed ID: 12582780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transitory evoked otoacoustic emissions in isolated high frequency, low frequency and middle frequency hearing].
    Mathis A; De Min N; Arnold W
    HNO; 1991 Feb; 39(2):55-60. PubMed ID: 2032875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion-product otoacoustic emission spectra and high-resolution audiometry in noise-induced hearing loss.
    Avan P; Bonfils P
    Hear Res; 2005 Nov; 209(1-2):68-75. PubMed ID: 16112827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.